Bayesian Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$8.52M |
| 2 |
NVIDIA
NVDA
|
+$6.41M |
| 3 |
Oracle
ORCL
|
+$5.76M |
| 4 |
Microsoft
MSFT
|
+$3.56M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$3.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNDK
Sandisk
SNDK
|
+$5.33M |
| 2 |
ExxonMobil
XOM
|
+$2.87M |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.69M |
| 4 |
Rocket Lab Corp
RKLB
|
+$2.61M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$2.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.57% |
| 2 | Consumer Discretionary | 16.88% |
| 3 | Financials | 11.54% |
| 4 | Healthcare | 9.13% |
| 5 | Materials | 6.89% |
Similar funds
Bayesian Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Bayesian Capital Management held 328 positions worth $156M, up 91% from $81.9M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bayesian Capital Management deployed $78.8M of net new capital in Q2 2026, opening 191 new positions and adding to 20 existing holdings. Its largest new stake was Alibaba: 67,999 shares worth $6.53M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Sandisk, an estimated $5.33M trimmed.
- Bayesian Capital Management's largest Q2 2026 buy was Alibaba: 67,999 shares worth $6.53M.
- Bayesian Capital Management added most to Oracle in Q2 2026, an estimated $5.76M increase.
- Bayesian Capital Management's biggest Q2 2026 reduction was Sandisk, cutting an estimated $5.33M.
- Bayesian Capital Management fully exited ExxonMobil in Q2 2026, selling an estimated $2.87M.
- Bayesian Capital Management's ten largest holdings make up 25% of its $156M portfolio in Q2 2026.
- Bayesian Capital Management opened 191 new positions and closed 105 in Q2 2026.
- Bayesian Capital Management's portfolio value rose 91% quarter-over-quarter to $156M.
Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.